Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alcon

This article was originally published in The Tan Sheet

Executive Summary

Acquires ICaps dietary supplement from La Haye Labs, the companies announce. Alcon "believes that ICaps fills an important market niche," the company says. Formulated to "promote healthy eyes," ICaps TR (time-release) contains beta-carotene, vitamins C, E, and B2, zinc acetate, manganese and selenium, while ICaps Plus adds copper. "As people grow older, they can experience eye problems such as macular degeneration and cataracts. Today's better-informed consumers are searching for potential ways to maintain their eye health," Alcon notes. La Haye says a "growing percentage of ophthalmologists and optometrists now recommend antioxidants for their patients"
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088883

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel